Application of Molecular or Genetic Markers in Liquid Biopsy for Urogenital Cancers

Dear Colleagues,

Urogenital cancers account for about 25% of total cancer incidence globally. Currently, the clinical diagnosis of urogenital cancer is usually established with a tissue biopsy after clinical examinations. A tissue biopsy is invasive, expensive, and painful for patients. A liquid biopsy is the sampling and analysis of non-solid tissue, such as blood, urine, and other biological fluids. During the last decade, molecular or genetic markers have been widely studied in urogenital cancers. In the meantime, liquid biopsy biotechnologies have been developing rapidly. Liquid biopsy has contributed to the progress of personalized medicine for cancer patients. The application of molecular or genetic markers in liquid biopsy for the management of urogenital cancers is an urgent task. New biotechnologies of liquid biopsy will complement the tissue biopsy towards precision medicine for urogenital cancer patients. The purpose of this Special Issue is to provide a platform for a wide range of reviews, research articles, short communications, and technical notes related to molecular or genetic studies in liquid biopsy for urogenital cancers. We particularly encourage submissions of original works that apply innovative biotechnologies to study molecular or genetic markers in extracellular vesicles (exosomes) to enhance the application of liquid biopsy for urogenital cancers. Clinical practice of liquid biopsy biomarkers could innovate patient management by enabling earlier diagnosis and personalized treatment strategies for urogenital cancer patients.

Prof. Dr. Guorong Li
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.